切换至 "中华医学电子期刊资源库"

中华腔镜泌尿外科杂志(电子版) ›› 2017, Vol. 11 ›› Issue (05) : 295 -301. doi: 10.3877/cma.j.issn.1674-3253.2017.05.002

所属专题: 文献

临床研究

经尿道前列腺电切联合内分泌治疗晚期前列腺癌膀胱出口梗阻疗效的荟萃分析
李涛1, 魏乔红1,(), 傅崇德1, 焦林1, 汤尧1, 谢圣陶1, 高辉1, 陈广瑜1   
  1. 1. 710100 陕西省西安市长安区,西安航天总医院泌尿外科
  • 收稿日期:2016-08-09 出版日期:2017-10-01
  • 通信作者: 魏乔红

Efficacy of transurethral resection of prostate plus endocrine therapy for bladder outlet obstruction in advanced prostate cancer: A systematic review

Tao Li1, Qiaohong Wei1,(), Chongde Fu1, Lin Jiao1, Yao Tang1, Shengtao Xie1, Hui Gao1, Guangyu Chen1   

  1. 1. Department of Urology, Xi'an Aerospace General Hospital, Xi'an 710100, China
  • Received:2016-08-09 Published:2017-10-01
  • Corresponding author: Qiaohong Wei
  • About author:
    Corresponding author: Wei Qiaohong, Email:
引用本文:

李涛, 魏乔红, 傅崇德, 焦林, 汤尧, 谢圣陶, 高辉, 陈广瑜. 经尿道前列腺电切联合内分泌治疗晚期前列腺癌膀胱出口梗阻疗效的荟萃分析[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2017, 11(05): 295-301.

Tao Li, Qiaohong Wei, Chongde Fu, Lin Jiao, Yao Tang, Shengtao Xie, Hui Gao, Guangyu Chen. Efficacy of transurethral resection of prostate plus endocrine therapy for bladder outlet obstruction in advanced prostate cancer: A systematic review[J/OL]. Chinese Journal of Endourology(Electronic Edition), 2017, 11(05): 295-301.

目的

系统评价经尿道前列腺电切术(TURP)联合内分泌治疗晚期前列腺癌(PCa)合并膀胱出口梗阻(BOO)的疗效。

方法

计算机检索Pubmed、Cochrane library、Sciverse、中国知网、维普及万方数据库,收集所有比较TURP联合内分泌治疗和单纯内分泌治疗晚期PCa的随机对照试验和非临床对照试验,检索时间均从建库至2016年7月。2名研究者根据纳入排除标准独立筛选文献、提取资料,应用Revman 5.3进行荟萃分析。

结果

共纳入7个研究,包含4个随机对照试验(RCT),3个非随机临床对照试验(CCT)。RCT的Meta分析结果显示:TURP联合内分泌组最大尿流率大于对照组[MD=3.11,95%CI(1.13,5.09),P=0.002],IPSS评分小于对照组[MD=-6.76,95%CI(-12.61,-0.91),P=0.02],而两组术后残余尿量差异无统计学意义[MD=-27.81,95%CI(-63.91,8.29),P=0.13]。对CCT的Meta分析结果显示:TURP联合内分泌组最大尿流率大于对照组[MD=5.49,95%CI(4.23,6.74),P<0.001],IPSS评分[MD=-7.69,95%CI(-11.69,-3.69),P=0.0002]及膀胱残余尿量[MD=-33.21,95%CI (-59.82,-6.61),P=0.01]低于对照组。同时,两组生存率差异无统计学意义[RR=1.06,95%CI(0.95,1.17),P=0.29]。描述性分析显示:TURP组术后PSA不呈现增加趋势。

结论

TURP联合内分泌治疗晚期PCa合并BOO患者,能够有效改善排尿困难症状,提高生活质量,且不影响总体生存率。

Objective

To systematically review the efficacy of transurethral resection of prostate (TURP) plus endocrine therapy (ET) for bladder outlet obstruction (BOO) in advanced prostate cancer (PCa).

Methods

Randomized controlled trials (RCTs) and non-randomized clinical controlled trials (CCTs) about TURP plus ET vs. ET for BOO in PCa patients were retrieved in Pubmed, Cochrane library, Sciverse, CNKI, VIP and Wanfang Database up to July, 2016. According to the inclusion and exclusion criteria, two reviewers independently screened the trials, extracted the data, conducted the Meta-analysis with Revman 5.3.

Results

Four RCTs and three CCTs were included. The results of meta-analysis based on RCT showed that, maximum urinary flow rate was higher [MD=3.11, 95%CI (1.13, 5.09), P=0.002] and IPSS was lower [MD=-6.76, 95%CI (-12.61, -0.91), P=0.02] in TURP plus ET group than those in ET group. However, there was no difference in residual urine volume in the two groups [MD=-27.81, 95%CI (-63.91, 8.29), P=0.13]. The results of meta-analysis based on CCT showed that, maximum urinary flow rate was higher [MD=5.49, 95%CI (4.23, 6.74), P<0.001], IPSS was lower [MD=-7.69, 95%CI (-11.69, -3.69), P=0.0002] and residual urine volume was lower [MD=-33.21, 95%CI (-59.82, -6.61), P=0.01] in TURP plus ET group than those in ET group. Meanwhile, no significant difference was observed in survival rate between the two groups [RR=1.06, 95%CI (0.95,1.17), P=0.29]. Descriptive analysis showed that PSA level did not increase in TURP plus ET.

Conclusion

TURP plus ET could relieve dysuresia symptoms, improve quality of life and did not influence the over survival rate for BOO in PCa patients

图1 文献筛选流程图
表1 纳入研究的基本特征
表2 纳入RCT的质量评价
表3 纳入CCT的质量评价
图2 两组最大尿流率比较的Meta分析
图3 两组IPSS比较的Meta分析
图4 两组膀胱残余尿量比较的Meta分析
图5 两组患者生存率比较的Meta分析
[1]
Siegel RL,Miller KD,Jemal A[J]. Cancer statistics,2016[J]. CA Cancer J Clin, 2016, 66(1): 7-30.
[2]
韩苏军,张思维,陈万青, 等. 中国前列腺癌发病现状和流行趋势分析[J]. 临床肿瘤学杂志, 2013, 18(4): 330-334.
[3]
Becker A,placke A,kluth L, et al. Holmium laser enucleation of the prostate is safe in patients with prostate cancer and lower urinary tract symptomsa retrospective feasibility study[J]. J Endourol, 2014, 28(3): 335-341.
[4]
Altay B,erkurt B,kiremit MC, et al. A comparison of 120 W laser photoselective vaporization versus transurethral resection of the prostate for bladder outlet obstruction by prostate cancer[J]. Urol Int, 2015, 94(3): 326-329.
[5]
张华俊,李月兵,郝建国, 等. 经尿道等离子电切联合非那雄胺治疗晚期前列腺癌致膀胱出口梗阻的临床价值[J]. 临床军医杂志, 2012, 40(3): 727-728.
[6]
刘斌,翟国炜. 等离子电切术联合抗雄激素治疗晚期前列腺癌膀胱出口梗阻临床观察[J]. 中国现代药物应用, 2014, 8(20): 117-118.
[7]
Javanmard B,Hassanzadeh Haddad A,Yaghoobi M, et al. Diode laser ablation of prostate and Channel transurethral resection of prostate in patients with prostate cancer and bladder outlet obstruction symptoms[J]. Urol J, 2014, 11(4): 1788-1792.
[8]
沈滔. 经尿道前列腺电切术治疗伴有膀胱出口梗阻前列腺癌的临床疗效分析[J]. 中国现代药物应用, 2016, 10(4): 39-40.
[9]
康健,沈海波,张良, 等. 经尿道前列腺切除治疗晚期前列腺癌并膀胱出口梗阻的疗效分析[J]. 临床泌尿外科杂志, 2007, 22(9): 661-663.
[10]
马彦,刘迪,李兵, 等. 经尿道前列腺电切术治疗晚期前列腺癌伴膀胱出口梗阻的疗效观察[J]. 临床泌尿外科杂志, 2013, 28(6): 450-452.
[11]
陶凌松,陶良俊,陈弋生, 等. 晚期前列腺癌伴膀胱出口梗阻TURP或α1A受体阻滞剂联合内分泌治疗的疗效分析[J]. 中华男科学杂志, 2015, 21(7): 626-629.
[12]
Moul JW,Davis R,Vaccaro JA, et al. Acute urinary retention associated with prostatic carcinoma[J]. J Urol, 1989, 141(6): 1375-1377.
[13]
Oefelein MG. Prognostic significance of obstructive uropathy in advanced prostate cancer[J]. Urology, 2004, 63(6): 1117-1121.
[14]
张浩斌,金成东. 隧道式TURP治疗伴膀胱出口梗阻的晚期前列腺癌[J]. 中国临床研究, 2010, 23(5): 384-385.
[15]
Clarke NW. The management of hormonerelapsed prostate cancer[J]. BJU Int, 2003, 92(8): 860-868.
[16]
Mazur AW,Thompson IM. Efficacy and morbidity of 'channel’ TURP[J]. Urology, 1991, 38(6): 526-528.
[17]
Crain DS,Amling CL,Kane CJ. Palliative transurethral prostate resection for bladder outlet obstruction in patients with locally advanced prostate cancer[J]. J Urol, 2004, 171(2 Pt 1): 668-671.
[18]
王江平,丁国富,王勤章. TURP治疗前列腺癌下尿路梗阻引发肿瘤血行转移风险的细胞学探索[J]. 中国医药科学, 2012, 2(20): 35-36.
[19]
杨堃. TURP治疗前列腺癌膀胱出口梗阻的适应证探讨[J]. 中国男科学杂志, 2011, 25(9): 53-56.
[20]
Marszalek M,Ponholzer A,Rauchenwald M, et al. Palliative transurethral resection of the prostate: functional outcome and impact on survival[J]. BJU Int, 2007, 99(1): 56-59.
[21]
刘磊,侯小飞,马潞林, 等. 晚期前列腺癌膀胱出口梗阻患者姑息性经尿道前列腺切除术疗效评价[J]. 北京大学学报:医学版, 2015, 47(4): 597-600.
[22]
李碧锦,凌凯南,林昌荣, 等. 经尿道等离子前列腺剜除术联合抗雄激素治疗中晚期局部前列腺癌伴膀胱出口梗阻的临床观察[J]. 中国性科学, 2016, 25(3): 14-16.
[23]
Cheng YT,Chiang PH,Chen YT, et al. Efficacy and safety of photoselective vaporization of the prostate in patients with prostatic obstruction induced by advanced prostate cancer[J]. Asian Journal of Surgery, 2011, 34(3): 135-139.
[24]
Krupski TL,Stukenborg GJ,Moon K, et al. The relationship of palliative transurethral resection of the prostate with disease progression in patients with prostate cancer[J]. BJU Int, 2010, 106(10): 1477-1483.
[25]
Qin XJ,Ma CG,Ye DW, et al. Tumor cytoreduction results in better response to androgen ablation--a preliminary report of palliative transurethral resection of the prostate in metastatic hormone sensitive prostate cancer[J]. Urol Oncol, 2012, 30(2): 145-149.
[26]
Zhang YY,Zhang ZG,Yu YL, et al. Early Channel transurethral resection of the prostate for patients with urinary retention after brachytherapy[J]. J Zhejiang Univ Sci B, 2014, 15(8): 756-760.
[1] 古娇娇, 李文涛. SHP基因影响乳腺癌内分泌治疗耐药的研究进展[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(02): 124-127.
[2] 穆星豆, 姜月, 张聚良. 细胞周期蛋白依赖性激酶4/6抑制剂在乳腺癌内分泌治疗中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(01): 47-51.
[3] 蒋敏, 刘馨竹, 李大伟, 冯柏塨, 申传安. 点阵CO2激光联合其他非手术方式治疗痤疮瘢痕有效性的网状荟萃分析[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(05): 429-439.
[4] 郑俊, 吴杰英, 谭海波, 郑安全, 李腾成. EGFR-MEK-TZ三联合分子的构建及其对去势抵抗性前列腺癌细胞增殖与凋亡的影响[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(05): 503-508.
[5] 王岩, 钱宏阳, 朱寅杰, 董柏君, 潘家骅, 薛蔚. 机器人辅助单孔腹膜外根治性前列腺切除治疗高危前列腺癌的瘤控效果初探[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(05): 435-440.
[6] 黄海, 程必盛, 黄健. 2024年欧洲泌尿外科学会年会:前列腺癌研究的前沿探索与未来趋势[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(03): 202-207.
[7] 曹飞, 庞俊. 前列腺癌免疫微环境中免疫抑制性细胞分类及其作用机制[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(02): 121-125.
[8] 张铭星, 刘文倩, 王以然, 赵泽恬, 袁欣怡, 丁留成. 江苏地区腹腔镜下前列腺癌根治术后一年夜尿症发生率及相关危险因素多中心回顾性研究[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(02): 141-145.
[9] 王永兴, 陈铭, 林灿彬, 何珊, 赵志敏, 黄家鹏, 李泓涛, 孟磊. 前列腺癌根治术后Hem-o-lok结扎夹突入膀胱致结石一例并文献复习[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(02): 175-177.
[10] 李俊涛, 张天佑, 叶雷, 郭强, 吴坚坚, 尧冰, 王德娟, 邱剑光. 保留"尿道系膜"的腹腔镜下前列腺根治性切除术后尿控情况的研究[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(01): 19-24.
[11] 李俊涛, 张天佑, 叶雷, 郭强, 吴坚坚, 尧冰, 王德娟, 邱剑光. 保留"尿道系膜"的腹腔镜下前列腺根治性切除术后尿控情况的研究[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(01): 19-24.
[12] 孙昭, 刘琪, 王殿琛, 姜建武, 符洋. 机器人对比腹腔镜及开放式腹股沟疝修补术的Meta 分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(05): 588-598.
[13] 李海亮, 俞云, 张星星, 陈管洁, 刘玲, 谢剑锋, 常炜. 经鼻高流量氧疗在危重症患者气管插管过程中效果的荟萃分析[J/OL]. 中华重症医学电子杂志, 2024, 10(03): 227-235.
[14] 张允耀, 王静, 范爱娟, 牟海萍. 超声诊断卵巢交界性肿瘤临床价值的荟萃分析[J/OL]. 中华诊断学电子杂志, 2024, 12(02): 85-89.
[15] 王海珍, 马永明, 姚可盈. 尿激酶治疗结核性包裹性胸腔积液疗效的系统评价与荟萃分析[J/OL]. 中华胸部外科电子杂志, 2024, 11(01): 53-61.
阅读次数
全文


摘要